Cardiovascular

Retinal microvascular changes are related to indicators of glymphatic dysfunction and small vessel disease in frontotemporal dementia.

TL;DR

Retinal microvascular alterations (sparser microvasculature) are related to SVD and glymphatic dysfunction in frontotemporal dementia.

Key Findings

FTD patients showed sparser retinal microvasculature compared to cognitively unimpaired controls.

  • 34 patients with clinically diagnosed FTD (82.4% behavioral variant FTD) and 34 cognitively unimpaired controls were included
  • Retinal vascular fractal dimension (FD) was used as the measure of retinal microvascular density/complexity
  • Color fundus photography was used to assess retinal vasculature
  • Difference was statistically significant (p < 0.05)
  • Generalized estimating equations were used to compare groups

FTD patients had lower DTI-ALPS (diffusion tensor imaging analysis along the perivascular space) values compared to controls, indicating glymphatic dysfunction.

  • DTI-ALPS is an MRI-derived glymphatic-related diffusion marker
  • Multimodal MRI was performed in all participants
  • Difference was statistically significant (p < 0.05)
  • Multivariable regression and partial Spearman correlations were used in analyses

FTD patients showed lower periventricular diffusivity compared to cognitively unimpaired controls.

  • Periventricular diffusivity is another MRI-derived glymphatic-related diffusion metric examined
  • Difference was statistically significant (p < 0.05)
  • This metric was assessed alongside DTI-ALPS as part of the glymphatic dysfunction indicators

FTD patients demonstrated higher cerebral small vessel disease (SVD) burden compared to controls.

  • SVD burden was assessed using multimodal MRI
  • Difference was statistically significant (p < 0.05)
  • SVD markers were examined in relation to retinal microvascular changes

Sparser retinal microvasculature was associated with reduced DTI-ALPS and lower periventricular diffusivity in FTD.

  • Associations were statistically significant (p < 0.05)
  • Analyses were performed using multivariable regression and partial Spearman correlations
  • This suggests a link between retinal microvascular changes and glymphatic dysfunction

Sparser retinal microvasculature was associated with greater SVD burden in FTD patients.

  • Association was statistically significant (p < 0.05)
  • This finding extends prior work linking retinal vascular alterations to cerebral small vessel disease in FTD
  • Multivariable regression and partial Spearman correlations were used

Sparser retinal microvasculature was associated with poorer cognition and greater disease severity in FTD.

  • Associations were statistically significant (p < 0.05)
  • Both cognitive measures and disease severity measures were examined as clinical outcomes
  • This links a non-invasive retinal measure to clinically meaningful outcomes in FTD

What This Means

This research suggests that changes in the tiny blood vessels of the retina (the light-sensitive layer at the back of the eye) are connected to two important disease processes in frontotemporal dementia (FTD): small vessel disease in the brain and dysfunction of the brain's waste-clearance system (called the glymphatic system). The study compared 34 FTD patients (most of whom had the behavioral variant of FTD) with 34 healthy controls using eye photography and specialized brain MRI scans. FTD patients had sparser retinal blood vessel networks, worse brain glymphatic function (measured by MRI markers called DTI-ALPS and periventricular diffusivity), and more small vessel disease in the brain. Importantly, the sparseness of retinal blood vessels was not only linked to these brain imaging abnormalities, but also to worse cognitive performance and greater overall disease severity in FTD patients. This suggests that the retina — which can be examined non-invasively using standard eye imaging equipment — may reflect what is happening in the brain in terms of vascular health and waste clearance. This research suggests that retinal imaging could potentially serve as an accessible, non-invasive window into brain health in FTD, offering a way to track disease-related vascular and glymphatic changes without requiring expensive or burdensome brain scans. However, the study was relatively small (34 patients), and further research is needed to confirm these findings and determine whether retinal measures could be useful as clinical biomarkers for FTD.

Have a question about this study?

Citation

Kwapong W, Chen Y, Chen X, Hou J, Lu H, Xu Y, et al.. (2026). Retinal microvascular changes are related to indicators of glymphatic dysfunction and small vessel disease in frontotemporal dementia.. Alzheimer's &amp; dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.71844